Interventional Cardiologists near Hasbrouck Heights, NJ

Care Philosophy: I am focused on integrating new technology and innovation into my clinical practice, and I am trained in the most current, cutting edge procedures. I believe that these new innovations minimize pain for the patient, while giving them the best possible surgical outcome and cosmetic result. After being trained in multiple disciplines, I am able to combine strategies to create a personalized treatment for each individual patient.

Biography: Dr. Annapoorna Kini, MD is a Cardiology Specialist who practices in New York, NY. She is 59 years old and has been practicing for 36 years. Dr. Annapoorna Kini, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Jeffrey Bander is a Cardiologist serving the Brooklyn area for more than 10 years. Dr. Bander is experienced in Echo Cardiogram, Exercise Treadmill Test and Eco stress. He is a professional member of the American Heart Association. Started practicing 2004. PROFESSIONAL ASSOCIATION American Heart Association HOSPITAL AFFILIATION Mount Sinai Hospital FORMS OF PAYMENT Payments taken through Mt. Sinai Hospital. INSURANCES ACCEPTED Aetna Anthem Blue Cross Blue Shield Blue Cross Blue Shield Cigna EmblemHealth Empire Blue Cross Blue Shield Empire Plan HealthFirst (NY) Medicare Multiplan PHCS Oxford (UnitedHealthcare) POMCO UnitedHealthcare Wellcare VNS NY Medicare Neighborhood Health Medicaid Metroplus Medicaid Oscar Exchange Magna Care Health Republic Exchange Magna Care Magna Care Choice Care

Biography: Dr. Angela Palazzo, MD is an Interventional Cardiology Specialist who practices in New York, NY. She is 72 years old and has been practicing for 45 years. Dr. Angela Palazzo, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Susheel K. Kodali, MD is the director of the Structural Heart and Valve Center at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital. Dr. Kodali is a professor in medicine at Columbia University Irving Medical Center. Board-certified in interventional cardiology, endovascular medicine, and cardiovascular disease, Dr. Kodali specializes in the percutaneous treatment of coronary artery and structural heart disease, and cardiac catheterization. Dr. Kodali was named New York Metro Area's Top Doctor by Castle Connolly's Top Doctors and New York Magazine's Top Doctors for over ten years. Dr. Kodali serves as the institutional co-investigator of the PARTNER trials and associated registries and is a member of the PARTNER trial steering committee. Dr. Kodali attended medical school at The University of California, Los Angeles. He did his residency and a fellowship program in clinical cardiology at the University of California, San Francisco, and a fellowship program in interventional cardiology at Columbia University Irving Medical Center.

Biography: Dr. George Dangas, MD is a Cardiology Specialist who practices in New York, NY. He is 61 years old. Dr. George Dangas, MD is affiliated with Mount Sinai Queens and Mount Sinai Hospital.

Biography: Dr. Hugo Rosero, DO is a Cardiology Specialist who practices in New York, NY. He is 71 years old and has been practicing for 39 years. Dr. Hugo Rosero, DO is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Robert Leber, MD is an Interventional Cardiology Specialist who practices in New York, NY. He is 66 years old and has been practicing for 39 years. Dr. Robert Leber, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Pedro Moreno, MD is an Interventional Cardiology Specialist who practices in New York, NY. He is 65 years old and has been practicing for 41 years. Dr. Pedro Moreno, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Deepika Misra, MD is an Interventional Cardiology Specialist who practices in New York, NY. She is 57 years old and has been practicing for 33 years. Dr. Deepika Misra, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Care Philosophy: It is an exciting time to be a part of Cardiology as advances in technology and therapeutics allow us to provide better care to our patients. As a clinical cardiologist, my goal is to make a positive impact in the cardiovascular health and lives of my patients. In addition to cutting edge technology, I believe that practicing medicine should be individualized, patient centric, and hold true to the ideals of compassion and human dignity.

Biography: Dr. George Fernaine, MD is an Interventional Cardiology Specialist who practices in New York, NY. He is 51 years old and has been practicing for 25 years. Dr. George Fernaine, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Joseph Sweeny, MD is an Internist who practices in New York, NY. He is 56 years old and has been practicing for 24 years. Dr. Joseph Sweeny, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Ramesh Gowda, MD is an Internist who practices in New York, NY. He is 56 years old and has been practicing for 24 years. Dr. Ramesh Gowda, MD is affiliated with Mount Sinai Morningside.

Biography: Dr. Vishal Kapur, MD is an Interventional Cardiology Specialist who practices in New York, NY. He is 48 years old and has been practicing for 24 years. Dr. Vishal Kapur, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Care Philosophy: About Dr. Khatri: "The ability to offer patients novel minimally invasive treatment strategies for atherosclerosis is what drew me to this field. But what I enjoy most about my job is the opportunity to build relationships and a bond of trust with my patients. I also take great pleasure in sharing my knowledge and experience with physicians in training."

Biography: Torsten P. Vahl, MD, is the Director of Translational Research and is an attending physician at the Columbia Structural Heart and Valve Center and Columbia Interventional Cardiovascular Care at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center. Dr. Vahl is also an Assistant Professor of Medicine at Columbia University Irving Medical Center. Dr. Vahl is board-certified in interventional cardiology, cardiovascular disease, echocardiography, and internal medicine. He specializes in the percutaneous treatment of coronary artery and structural heart disease and cardiac catheterization. His primary focus is on transcatheter aortic valve replacements, transcatheter mitral valve repair and replacement, and left atrial appendage closure. Dr. Vahl is also very involved in many preclinical and first-in-human studies through his association with the Cardiovascular Research Foundation. For example, Dr. Vahl led the ALIGN-AR trial as a national PI, a position that evolved out of his experience with the device from the preclinical studies. Dr. Vahl frequently proctors other interventional cardiologists on TAVR in aortic regurgitation with the Trilogy valve and on TMVR with the Cephea valve. Within the left atrial appendage closure, Dr. Vahl has been very active in developing our intracardiac echo program which allows patients to get this procedure without the need for general anesthesia and TEE. Dr. Vahl attended medical school at the Philipps-Universitt in Marburg, Germany. He did his internal medicine residency and his cardiovascular disease fellowship at Mount Sinai Medical Center in New York City. He also completed a fellowship in both interventional cardiology and structural interventional cardiology, focusing on valvular heart disease, at Columbia University Irving Medical Center.

Care Philosophy: My professional focus is equally directed on the direct care of patients intimately combined with teaching Fellows diagnostic and interventional therapeutic cardiac procedures in the catheterization laboratory. I consider it a significant privilege to work side by side with so many other experts in the provision of excellent health care. In particular Faculty status at Cornell provides me with the time and opportunity to practice the discipline of cardiac catheterization in the most professional manner. I greatly enjoy the responsibility of teaching Fellows the skills and importance of the catheterization laboratory. Combining this with an interest in clinically based outcomes type research completes my busy schedule.

Care Philosophy: As an interventional cardiologist, I am very comfortable performing a number of advanced, minimally-invasive cardiovascular procedures and have helped many patients this way. However, not every patient needs invasive tests and procedures; the key (and the most important part of clinical medicine) is tailoring the right therapies to the right patients! Our team will work with you to sort out what is best for you, given your individual situation and medical conditions.

Care Philosophy: Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Biography: An international leader in pediatric cardiology, Christopher J. Petit, MD, has particular expertise in minimally invasive techniques to treat valve disease and complex congenital heart disease. Recognized for his clinical innovations, development of specialty programs, and his research accomplishments, Dr. Petit believes that the field of pediatric cardiology advances through collaborative discovery. He has been an active clinician-scientist, working to determine the best treatments for patients with congenital heart disease. Dr. Petit founded and currently serves as President of the Congenital Cardiac Research Collaborative.

Biography: Jeffrey W. Moses, MD, is a renowned interventional cardiologist and Professor of Medicine at Columbia University Medical Center. Dr. Moses serves as the Director of Interventional Cardiovascular Therapeutics at Columbia Interventional Cardiovascular Care and the Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY.With a track record of over 18,000 interventional procedures, Dr. Moses is an accomplished researcher. He has served as a lead investigator for numerous national and international clinical studies and authored over 600 publications, many focusing on the effectiveness and safety of coronary stent placement. Notably, his pivotal role in a 2002 clinical trial resulted in the first U.S. FDA approval of a drug-coated stent, now widely used in American interventional procedures.Dr. Moses contributed to the Executive Committee of the PARTNER trial, which introduced the first transcatheter aortic valve for clinical use in the U.S. A pioneer in various approaches, including minimally invasive surgery, angioplasty, gene therapy, and novel imaging technologies, he extends the application of interventional cardiovascular procedures. He is a fellow in multiple professional societies and serves on the editorial board as a reviewer for numerous peer-reviewed journals.Dr. Moses serves on the Board of the Cardiovascular Research Foundation (CRF); and continues to make formidable contributions in the areas of clinical research and educational activities in interventional vascular therapy.Before his tenure at Columbia, Dr. Moses held a professorship in Clinical Medicine at New York University School of Medicine. He also played key roles at The New York Hospital (now NewYork-Presbyterian), where he served as the Associate Director of the Adult Cardiac Catheterization Laboratory and Director of Clinical Electrophysiology.Dr. Moses completed medical school at the University of Pennsylvania School of Medicine and his internship, residency, and fellowship in Cardiology at the Presbyterian University of Pennsylvania Medical Center.

Biography: Christopher Irobunda, MD, is an Associate Professor at CUMC and an interventionalist. He is also Vice Chair of the Faculty Development focusing on Diversity, Equity & Inclusion within the Department of Medicine. He trained as a general and interventional cardiologist. Dr. Irobunda has been a full-time faculty since 2003. He obtained his MD/PhD in the Medical Scientist Training Program at the Albert Einstein College of Medicine in the Bronx, NY. His PhD was in Molecular Pharmacology, specifically on the cyclic Adenosine MonoPhosphate/beta-adrenergic signal transduction system. He subsequently completed an internship and residency in internal medicine at New York University Medical Center, followed by his General and Interventional Cardiology Fellowship here at Columbia University Medical Center. After completing his medical training and research study, he shifted his concentration to patient care and the education of aspiring young physicians. Dr. Irobunda is ardently dedicated to uncompromised patient care and teaching. His primary focus is individualized patient care and patient advocacy. Given his training as a medical scientist, it is hardly surprising that he is a keen diagnostician. He has a penchant for complex cardiac issues and other medical problems that can sometimes mask or aggravate the cardiac disease. His aptitude for unraveling these medical conundrums has led to medical diagnoses for patients who have come to him for second and even third opinions. However, above all else, his true genius is his ability to relate to his patients with intelligence, curiosity, patience, compassion, and humor. His ability to waylay even the most apprehensive of patients with his aura of reassurance and understanding has garnered him a continually growing medical practice. Again and again, individuals will refer family members and friends because of the empathy and level of care constantly provided. Indeed, his unceasing diligence has led him to become a physician member of Columbia University Medical Centers Patient Facilitated Services, an organization directed at patient satisfaction and outreach. Dr. Irobunda has also been the primary cardiologist for patients undergoing liver transplant evaluations at New York Presbyterian since 2004. When not in his private practice, he takes great pleasure in helping train the new influx of physicians in the only ethical way to practice medicinepatient-centered care. Dr. Irobunda has been a Supervisor and Attending Faculty for the Fundamentals of Clinical Medicine for First Year Medical Students at Columbia University College of Physicians and Surgeons since 2011, a program that endeavors to instill exceptional patient-doctor communication and trust. He encourages future medical practitioners to listen to the patient and learn to interpret and analyze the information being imported; to realize that the seemingly insignificant details sometimes lead to the culprit of an individual's illness. He has been a lecturer with International Postgraduate Organization for Knowledgetransfer, Research, and Teaching Excellent Students (IPOKRaTES) in Europe. IPOKRaTES offers opportunities for physicians from a plethora of countries to observe and gain instruction regarding differing methods in patient care practices. Since the summer of 2012, Dr. Irobunda has become involved in New York Presbyterian Hospital's Lange Youth Program, which seeks to prepare and enumerate the rigors of medical school for high school students. Dr. Irobunda is active in numerous community outreach organizations-Abyssian Baptist Church (NY), JP Morgan Chase Employee Education Program, Riverside Church Seniors, and Sister to Sister: The Women's Heart Health Foundation, to name a few. He seeks to educate the public on cardiovascular issues and ways to make everyday lifestyle modifications to help reduce these risks. In addition to being an interventional cardiologist who can perform angioplasties and stent placements, he emphasizes the prevention and treatment of heart disease through diet, exercise, and medical therapy.

Care Philosophy: At NOVA Cardiovascular Care, we strive for high quality healthcare and patient satisfaction. We put our efforts to provide meaningful and prompt cardiac care to primary care physicians as well as their patients. Our mission at NOVA Cardiovascular Care has been to utilize advanced diagnostic equipment, procedures and techniques while working closely with primary care doctors and other specialists to treat the patient as a whole.